Terazosin Hydrochloride Capsule
Product Images NDC 63629-4525

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Terazosin Hydrochloride (NDC 63629-4525). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl636294525)

Label for TERAZOSIN HYDROCHLORIDE 1 mg oral capsules by Bryant Ranch Prepack. The label displays product name and strength prominently in black text on a red background, with storage instructions including room temperature and light-resistant container. It also shows comparison to Hytrin 1 mg capsules and includes lot number and barcode.*

FDA Label Image

Terazosin Hydrochloride Chemical Structure (Terazosin Hydrochloride Capsules 1)

Chemical structure of Terazosin Hydrochloride, showing its molecular framework including aromatic rings, nitrogen atoms, and a hydrochloride salt indicated by HCl.*

FDA Label Image

Figure 1 (Terazosin Hydrochloride Capsules 2)

Two line graphs comparing the effects of Terazosin and Placebo over a three-month period. The left graph shows mean change in total symptom score from baseline, where Terazosin shows a progressive decrease while Placebo remains relatively constant. The right graph shows mean increase in peak flow rate (mL/sec) from baseline, where Terazosin demonstrates a marked increase whereas Placebo shows little change. Sample sizes for each group are indicated for each time point.*

FDA Label Image

Figure 2 (Terazosin Hydrochloride Capsules 3)

A line graph showing mean change from baseline over a 30-month period. The x-axis represents time in months, and the y-axis shows mean change values. Two data series are plotted with markers; both show a decreasing trend in mean change from baseline, with several points marked by asterisks indicating significance.*

FDA Label Image

Figure 3 (Terazosin Hydrochloride Capsules 4)

A line graph showing the mean change from baseline (measured in mL/sec) over a 30-month period. The x-axis represents time in months, with data points at specific intervals from 0 to 30 months. The graph includes error bars and several points marked with asterisks indicating statistical significance.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.